Avanos Medical Inc.

NYSE: AVNS · Real-Time Price · USD
11.04
0.08 (0.73%)
At close: Aug 15, 2025, 2:49 PM

Avanos Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-463.2M -382.1M -388.2M 20.1M 12.1M -60.3M -61.3M -55.4M -35.3M 44.2M 50.5M 43.6M -7.9M 18.6M 5.2M -52M 2.4M -38.5M
Depreciation & Amortization
42.4M 43.7M 45.5M 45.9M 45.2M 45.4M 46.1M 48M 48.6M 48.7M 47.7M 43.8M 41.8M 39.7M 38.3M 39.6M 40.7M 42M
Stock-Based Compensation
14.3M 14M 13.8M 14M 15.3M 15.4M 15.8M 15.8M 16M 16.1M 15.9M 14.9M 14.3M 13.9M 13.2M 13.4M 13.3M 12.7M
Other Working Capital
-9.6M 19.4M 5.7M -19.1M -12.6M -44M -44.8M -8.6M -12.7M -4.6M -4.1M -900K 14.7M 11.5M 38.5M -26.2M -49.1M -57.9M
Other Non-Cash Items
472.6M 433M 452.2M 53.1M 53.6M 80.4M 57.8M 62.3M 61.5M 25.7M 44.8M 47.2M 42.6M 19.7M 3.8M 19.9M 21.8M 17.2M
Deferred Income Tax
n/a 9.6M 9.6M 3M -900K -10.5M -10.5M -3.6M 300K 400K n/a 11.7M 49M 2.2M -3.3M 33M -24.7M 20.9M
Change in Working Capital
47.3M 65M 37.2M -11.2M 5.7M -18.6M -15.5M -13.7M -38.4M -25.1M -24.3M -8.1M 3.9M 10.2M 26M -21.8M -39.3M -54.3M
Operating Cash Flow
113.4M 134.4M 100.7M 55.5M 61.6M 31.2M 32.4M 53.4M 52.7M 82.3M 90.9M 109.4M 104.2M 92.5M 87.4M 36.3M 14.2M n/a
Capital Expenditures
-25.5M -20.4M -17.8M -18.9M -19.8M -17.9M -17.8M -16.8M -18.2M -18.3M -19.3M -19.2M -18.7M -20.4M -21.1M -21.4M -19.6M -20.7M
Cash Acquisitions
-4.6M -2.4M 2.1M 89M 44M 41.5M 39.4M -163.6M -118M -115.5M -232.2M -116.1M -116.7M -116.7M n/a 4M n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-11.8M -17.7M -15.6M 76.2M 40.2M 43.6M 41.5M 68.6M 114.2M 116.7M n/a -124M -124.6M -124.6M -7.9M -4M -8M -8M
Investing Cash Flow
-41.9M -34.6M -27.5M 61.1M 24.2M 23.6M 21.6M -64.3M -20.1M -17.7M -135.4M -135.3M -135.4M -137.1M -21.1M -21.4M -23.6M -24.7M
Debt Repayment
-70.2M -69.3M -33.6M -102.9M -34.7M -34.7M -64.7M 10.3M -44.7M -43.2M 103.4M 110M 90M 80M -50M -104.8M -84.8M -74.8M
Common Stock Repurchased
-3.2M -5.9M -12.8M -18.9M -28M -27.1M -19.1M -13.3M -15.1M -27.2M -45.5M -56M -45.1M -30.9M -11.5M -1.1M -1.1M -900K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.4M -3.4M -3.4M -3.4M -3.4M -3.4M -3.4M
Other Financial Acitivies
-2.3M -2.3M -2.7M -14.4M -10.8M -10.8M -10.2M 1.6M 1.5M -700K -1.2M -1.2M -1.1M 1.5M 6.2M 8.1M 5.3M 5.5M
Financial Cash Flow
-75.7M -77.5M -49.1M -136.4M -73.7M -72.8M -94.2M -1.4M -58.3M -71.1M 56.7M 52.8M 43.8M 50.6M -55.3M -97.8M -80.6M -70.2M
Net Cash Flow
-1.9M 21.2M 20M -18.1M 10.4M -19.9M -40M -9.9M -24.7M -8.6M 9.2M 19.2M 6.6M 4.2M 7M -82.2M -85.1M -87.6M
Free Cash Flow
87.9M 114M 82.9M 36.6M 41.8M 13.3M 14.6M 36.6M 34.5M 64M 71.6M 90.2M 85.5M 72.1M 66.3M 14.9M -5.4M -20.7M